Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2150 for:    MULTIPLE SCLEROSIS
Previous Study | Return to List | Next Study

Reliability and Validity of the Turkish Version of the Multiple Sclerosis Knowledge Questionnaire

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03927092
Recruitment Status : Completed
First Posted : April 25, 2019
Last Update Posted : April 29, 2019
Sponsor:
Information provided by (Responsible Party):
Ece Cinar, Ege University

Brief Summary:
Multiple Sclerosis Knowledge Questionnaire (MSKQ) is a 25-item self administered questionnaire assessing a patient's level of knowledge regarding multiple sclerosis (MS). Turkish translation of the questionnaire was prepared and participants in the annual patient education seminar in the investigators' university hospital were asked to answer these questions before and after the seminar.Their results were analysed to assess their level of knowledge about their disease.

Condition or disease Intervention/treatment
Multiple Sclerosis Other: Multiple Sclerosis Knowledge Questionnaire

Detailed Description:
Multiple sclerosis knowledge questionnaire was developed in Italy (1) and was reported to be useful in measuring patients' level of knowledge about their disease. The English version of the questionnaire was translated into Turkish by three physicians than back translated into English by two separate linguists. Initially 5 MS patients were asked to answer this first version of the questionnaire and report any difficulties in understanding the items. Their feedback was used to give the questionnaire its final shape. For the validation stage, patients that were diagnosed as having MS and who attended the annual MS patient education seminar were enrolled into the study. They answered the questions twice, before and after the seminar. Their answers were analysed to measure their level of knowledge about their disease.

Layout table for study information
Study Type : Observational
Actual Enrollment : 58 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Reliability and Validity of the Turkish Version of the Multiple Sclerosis Knowledge Questionnaire
Actual Study Start Date : May 2016
Actual Primary Completion Date : May 2016
Actual Study Completion Date : May 2016

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Multiple Sclerosis patients
Patients that attended an annual patient education seminar at the investigators' university hospital were asked to fill out the Turkish version of the Multiple Sclerosis Knowledge Questionnaire
Other: Multiple Sclerosis Knowledge Questionnaire
A 25-item self-administered questionnaire




Primary Outcome Measures :
  1. reliability of the questionnaire [ Time Frame: 1 day ]
    Internal consistency was evaluated by the coefficient alpha (α) or Cronbach's coefficient, and if the Cronbach's coefficient value was greater than 0.7, it was considered as an acceptable internal consistency


Secondary Outcome Measures :
  1. Number of correct answers [ Time Frame: 1 day ]
    To assess the distribution of correct and false answers and the levels of significance, Chi-square test was used. To compare the two questionnaires answered by the same patient before and after the seminar Wilcoxon signed-rank test was used.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients diagnosed as having multiple sclerosis.
Criteria

Inclusion Criteria:

  • Diagnosed as having Multiple Sclerosis
  • Attends the annual patient education seminar at the investigators' university hospital
  • Older than 18 years of age
  • Can read and write

Exclusion Criteria:

  • Does not accept to answer the questionnaire
  • Unable to answer the questions due to a cognitive impairment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03927092


Sponsors and Collaborators
Ege University
Investigators
Layout table for investigator information
Principal Investigator: Ece Cinar, M.D. Ege University School of Medicine
Study Director: Yesim Akkoc, M.D. Ege University School of Medicine
Principal Investigator: Funda Calis, M.D. Ege University School of Medicine
Principal Investigator: Musa Baklaci, M.D. Ege University School of Medicine
Principal Investigator: Ozgul Ekmekci, M.D. Ege University School of Medicine
Principal Investigator: Ayse N Yuceyar, M.D. Ege University School of Medicine

Publications:
Layout table for additonal information
Responsible Party: Ece Cinar, Principal investigator, Ege University
ClinicalTrials.gov Identifier: NCT03927092     History of Changes
Other Study ID Numbers: 16-4.1/19
First Posted: April 25, 2019    Key Record Dates
Last Update Posted: April 29, 2019
Last Verified: April 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Ece Cinar, Ege University:
multiple sclerosis
surveys and questionnaires
diagnostic self evaluation

Additional relevant MeSH terms:
Layout table for MeSH terms
Sclerosis
Multiple Sclerosis
Pathologic Processes
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Nervous System Diseases
Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases